Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2026)

Amneal Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $624.0 million for Q1 2026.

• In Q1 2026, Inventory Average rose 2.8% year-over-year to $624.0 million; the TTM figure through Mar 2026 stood at $624.0 million (up 2.8% YoY), while the FY2025 annual figure was $609.4 million, up 2.09% from the prior year.
• Inventory Average was $624.0 million for Q1 2026 at Amneal Pharmaceuticals, up from $610.4 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $624.0 million in Q1 2026 to a low of $500.8 million in Q1 2022.
• Historically, Inventory Average has averaged $571.1 million across 5 years, with a median of $576.0 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory Average climbed 8.71% in 2024, then rose 0.99% in 2025.
• A 5-year view of Inventory Average shows it stood at $537.3 million in 2022, then increased by 7.75% to $578.9 million in 2023, then increased by 4.4% to $604.4 million in 2024, then advanced by 0.99% to $610.4 million in 2025, then gained by 2.22% to $624.0 million in 2026.
• The last three Inventory Average figures came in at $624.0 million (Q1 2026), $610.4 million (Q4 2025), and $611.7 million (Q3 2025), per Business Quant data.